Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Cost-effectiveness of screening for microalbuminuria among African Americans.

Hoerger TJ, Wittenborn JS, Zhuo X, Pavkov ME, Burrows NR, Eggers P, Jordan R, Saydah S, Williams DE.

J Am Soc Nephrol. 2012 Dec;23(12):2035-41. doi: 10.1681/ASN.2012040347.

PMID:
23204444
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland.

Kessler R, Keusch G, Szucs TD, Wittenborn JS, Hoerger TJ, Br├╝gger U, Wieser S.

Swiss Med Wkly. 2012 Feb 3;142:w13508. doi: 10.4414/smw.2012.13508.

PMID:
22307760
[PubMed - indexed for MEDLINE]
Free Article
3.

A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):463-73. doi: 10.1053/j.ajkd.2009.11.017. Epub 2010 Feb 8.

PMID:
20116910
[PubMed - indexed for MEDLINE]
4.

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.

Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ; Prevention of Renal and Vascular End Stage Disease Study Group.

Clin Ther. 2010 Jun;32(6):1103-21. doi: 10.1016/j.clinthera.2010.06.013.

PMID:
20637965
[PubMed - indexed for MEDLINE]
5.

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

Golan L, Birkmeyer JD, Welch HG.

Ann Intern Med. 1999 Nov 2;131(9):660-7.

PMID:
10577328
[PubMed - indexed for MEDLINE]
6.

Albuminuria and racial disparities in the risk for ESRD.

McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G.

J Am Soc Nephrol. 2011 Sep;22(9):1721-8. doi: 10.1681/ASN.2010101085. Epub 2011 Aug 25.

PMID:
21868498
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Kidney disease progression and screening cost-effectiveness among African Americans.

Vargas RB, Norris KC.

J Am Soc Nephrol. 2012 Dec;23(12):1915-6. doi: 10.1681/ASN.2012101028. Epub 2012 Nov 15. No abstract available.

PMID:
23160510
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

PMID:
16095545
[PubMed - indexed for MEDLINE]
Free Article
9.

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation.

Kiberd BA, Jindal KK.

BMJ. 1995 Dec 16;311(7020):1595-9.

PMID:
8555801
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.

Howard K, White S, Salkeld G, McDonald S, Craig JC, Chadban S, Cass A.

Value Health. 2010 Mar-Apr;13(2):196-208. doi: 10.1111/j.1524-4733.2009.00668.x. Epub 2009 Oct 29.

PMID:
19878493
[PubMed - indexed for MEDLINE]
11.

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.

Nephrol Dial Transplant. 2008 Apr;23(4):1216-23. doi: 10.1093/ndt/gfn082.

PMID:
18359872
[PubMed - indexed for MEDLINE]
Free Article
12.

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).

Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ; PREVEND IT Study Group.

Clin Ther. 2006 Mar;28(3):432-44.

PMID:
16750458
[PubMed - indexed for MEDLINE]
13.

Racial differences in the incidence of chronic kidney disease.

Muntner P, Newsome B, Kramer H, Peralta CA, Kim Y, Jacobs DR Jr, Kiefe CI, Lewis CE.

Clin J Am Soc Nephrol. 2012 Jan;7(1):101-7. doi: 10.2215/CJN.06450611. Epub 2011 Nov 10.

PMID:
22076879
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Racial differences in health-related quality of life among hemodialysis patients.

Unruh M, Miskulin D, Yan G, Hays RD, Benz R, Kusek JW, Meyer KB; HEMO Study Group.

Kidney Int. 2004 Apr;65(4):1482-91.

PMID:
15086492
[PubMed - indexed for MEDLINE]
15.

A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):452-62. doi: 10.1053/j.ajkd.2009.11.016. Epub 2010 Feb 8.

PMID:
20116911
[PubMed - indexed for MEDLINE]
16.

Benefits and costs of interventions to improve breast cancer outcomes in African American women.

Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Muennig P, Chavez Y, Cullen J, Fahs M.

J Clin Oncol. 2004 Jul 1;22(13):2554-66. Epub 2004 Jun 1.

PMID:
15173213
[PubMed - indexed for MEDLINE]
Free Article
17.

African-Americans on maintenance dialysis: a review of racial differences in incidence, treatment, and survival.

Price DA, Owen WF Jr.

Adv Ren Replace Ther. 1997 Jan;4(1):3-12. Review.

PMID:
8996615
[PubMed - indexed for MEDLINE]
18.

End-stage renal disease in African-Americans.

Boone CA.

Nephrol Nurs J. 2000 Dec;27(6):597-600. Review.

PMID:
16649339
[PubMed - indexed for MEDLINE]
19.

Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.

Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG.

Am J Kidney Dis. 2008 Aug;52(2):251-61. doi: 10.1053/j.ajkd.2008.03.019. Epub 2008 May 12.

PMID:
18468746
[PubMed - indexed for MEDLINE]
20.

The primary care perspective on routine urine dipstick screening to identify patients with albuminuria.

Samal L, Linder JA.

Clin J Am Soc Nephrol. 2013 Jan;8(1):131-5. doi: 10.2215/CJN.12681211. Epub 2012 Aug 23.

PMID:
22917702
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk